Details

NameSymbolSector
ORCHID PHARMA LIMITEDORCHPHARMAPharmaceuticals
Open
594
High
594
Low
578.6
Close
585.3
Volume
30841
Exchange
nse
Time
28-Apr-2026

Outlook

Score:  

2.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Orchid Pharma is  
None
Estimated Stoploss of Orchid Pharma is ₹  
594
Orchid Pharma has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Orchid Pharma is  
Unpredictableℹ
. 

Trend

Orchid Pharma is in  
Uptrendℹ
. 
Price of Orchid Pharma is  
Upℹ
 by  

4.68

%. 
Target
Buy @ 

558.05

Sell @ 

714.95

Current @ 

585.3

Volume

The trade volumes of Orchid Pharma have become  
Deficientℹ
Though the volume trend for Orchid Pharma appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Orchid Pharma is  

Down

 by  

63.83

% 

Valuation

The current market price of Orchid Pharma is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 1687cr and total assets worth ₹ 1687cr, the balance sheet of Orchid Pharma is:  
Balancedℹ
. 
Cashflow
Orchid Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 17cr

. It is  
Upℹ
 by  

194.44

%. 

(*Mar 2025)

27.14% i.e. ₹ 19cr earned in operatingℹ
37.14% i.e. ₹ 26cr spent in investingℹ
35.71% i.e. ₹ 25cr earned in financingℹ
0% in otherℹ
Orchid Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 18cr

. It is  
Downℹ
 by  

200

%. 

(*Mar 2024)

20.7% i.e. ₹ 125cr earned in operatingℹ
51.66% i.e. ₹ 312cr spent in investingℹ
27.65% i.e. ₹ 167cr earned in financingℹ
0% in otherℹ
Income
The income of Orchid Pharma is  

₹ 204cr

 and  

Loss

 is :  

₹ 3cr

(*Sep 2025)

Orchid Pharma Losses increased by:  

123.08

% and Income is Up by:  

10.87

% 

(*Sep 2025)

The income of Orchid Pharma is  

₹ 184cr

 and  

Profit

 is :  

₹ 13cr

(*Jun 2025)

Orchid Pharma Profit is down by:  

31.58

% and Income is Down by:  

23.65

% 

(*Jun 2025)

The income of Orchid Pharma is  

₹ 241cr

 and  

Profit

 is :  

₹ 19cr

(*Mar 2025)

Orchid Pharma Profit is down by:  

13.64

% and Income is Up by:  

7.11

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.